165 related articles for article (PubMed ID: 38459191)
41. A fully integrated microfluidic platform for highly sensitive analysis of immunochemical parameters.
Lutz S; Lopez-Calle E; Espindola P; Boehm C; Brueckner T; Spinke J; Marcinowski M; Keller T; Tgetgel A; Herbert N; Fischer T; Beiersdorf E
Analyst; 2017 Nov; 142(22):4206-4214. PubMed ID: 29043325
[TBL] [Abstract][Full Text] [Related]
42. Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(2):1-125. PubMed ID: 34055110
[TBL] [Abstract][Full Text] [Related]
43. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
Wu YR; Chen SB; Sun K; Huang MR; Zhang YQ; Chen S
Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):728-32. PubMed ID: 17229370
[TBL] [Abstract][Full Text] [Related]
44. A chemiluminescence immunoassay for the detection of NT-proBNP.
Chen YY; Li SL; Lin HL; Li WD; Zhu XZ; Zhang HL
Anal Biochem; 2020 Dec; 611():113950. PubMed ID: 32919941
[TBL] [Abstract][Full Text] [Related]
45. A sandwich-type electrochemical immunosensor using trimetallic nanozyme as signal amplification for NT-proBNP sensitive detection.
Zhang B; Li F; Han F; Yang H; Jiang C; Tan S; Tu J; Qiao B; Wang X; Wu Q
Bioelectrochemistry; 2022 Jun; 145():108075. PubMed ID: 35101800
[TBL] [Abstract][Full Text] [Related]
46. Comparison of pleural fluid N-terminal pro-brain natriuretic peptide and brain natriuretic-32 peptide levels.
Long AC; O'Neal HR; Peng S; Lane KB; Light RW
Chest; 2010 Jun; 137(6):1369-74. PubMed ID: 20139229
[TBL] [Abstract][Full Text] [Related]
47. Introduction of multilayered magnetic core-dual shell SERS tags into lateral flow immunoassay: A highly stable and sensitive method for the simultaneous detection of multiple veterinary drugs in complex samples.
Tu J; Wu T; Yu Q; Li J; Zheng S; Qi K; Sun G; Xiao R; Wang C
J Hazard Mater; 2023 Apr; 448():130912. PubMed ID: 36758436
[TBL] [Abstract][Full Text] [Related]
48. Plasma NT-proBNP levels associated with cardiac structural abnormalities in asymptomatic health examinees with preserved ejection fraction: a retrospective cross-sectional study.
Nah EH; Kim SY; Cho S; Kim S; Cho HI
BMJ Open; 2019 Apr; 9(4):e026030. PubMed ID: 31005928
[TBL] [Abstract][Full Text] [Related]
49. Determination and stability of N-terminal pro-brain natriuretic peptide in saliva samples for monitoring heart failure.
Bellagambi FG; Petersen C; Salvo P; Ghimenti S; Franzini M; Biagini D; Hangouët M; Trivella MG; Di Francesco F; Paolicchi A; Errachid A; Fuoco R; Lomonaco T
Sci Rep; 2021 Jun; 11(1):13088. PubMed ID: 34158583
[TBL] [Abstract][Full Text] [Related]
50. Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication.
Ordu S; Ozhan H; Alemdar R; Aydin M; Caglar O; Yuksel H; Kandis H
Tex Heart Inst J; 2012; 39(1):30-5. PubMed ID: 22412224
[TBL] [Abstract][Full Text] [Related]
51. Poly(amidoamine)-coated magnetic particles for enhanced detection of Schistosoma circulating anodic antigen in endemic urine samples.
Markwalter CF; Corstjens PLAM; Mammoser CM; Camps G; van Dam GJ; Wright DW
Analyst; 2018 Dec; 144(1):212-219. PubMed ID: 30328427
[TBL] [Abstract][Full Text] [Related]
52. N-terminal-pro-B-type natriuretic peptide (NT-proBNP): reference range for Chinese apparently healthy people and clinical performance in Chinese elderly patients with heart failure.
Shi X; Xu G; Xia T; Song Y; Lin Q
Clin Chim Acta; 2005 Oct; 360(1-2):122-7. PubMed ID: 16002063
[TBL] [Abstract][Full Text] [Related]
53. The colloidal gold nanoparticle-based lateral flow immunoassay for fast and simple detection of plant-derived doping agent, higenamine.
Nuntawong P; Ochi A; Chaingam J; Tanaka H; Sakamoto S; Morimoto S
Drug Test Anal; 2021 Apr; 13(4):762-769. PubMed ID: 33217196
[TBL] [Abstract][Full Text] [Related]
54. Direct immunochemiluminescent assay for proBNP and total BNP in human plasma proBNP and total BNP levels in normal and heart failure.
Nishikimi T; Okamoto H; Nakamura M; Ogawa N; Horii K; Nagata K; Nakagawa Y; Kinoshita H; Yamada C; Nakao K; Minami T; Kuwabara Y; Kuwahara K; Masuda I; Kangawa K; Minamino N; Nakao K
PLoS One; 2013; 8(1):e53233. PubMed ID: 23365636
[TBL] [Abstract][Full Text] [Related]
55. Self-Assembling Allochroic Nanocatalyst for Improving Nanozyme-Based Immunochromatographic Assays.
Song Y; Cai X; Ostermeyer G; Yu J; Du D; Lin Y
ACS Sens; 2021 Jan; 6(1):220-228. PubMed ID: 33433202
[TBL] [Abstract][Full Text] [Related]
56. Application of a SERS-based lateral flow immunoassay strip for the rapid and sensitive detection of staphylococcal enterotoxin B.
Hwang J; Lee S; Choo J
Nanoscale; 2016 Jun; 8(22):11418-25. PubMed ID: 26790112
[TBL] [Abstract][Full Text] [Related]
57. Sensitive immunosensor for N-terminal pro-brain natriuretic peptide based on N-(aminobutyl)-N-(ethylisoluminol)-functionalized gold nanodots/multiwalled carbon nanotube electrochemiluminescence nanointerface.
Zhang H; Han Z; Wang X; Li F; Cui H; Yang D; Bian Z
ACS Appl Mater Interfaces; 2015 Apr; 7(14):7599-604. PubMed ID: 25801201
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of analytical performances using standardized analytical protocols and comparison of clinical results of the new ADVIA BNP and NT-proBNP immunoassays for the Centaur XPT platform.
Masotti S; Musetti V; Prontera C; Storti S; Ndreu R; Passino C; Zucchelli G; Clerico A
Clin Chem Lab Med; 2019 May; 57(6):911-917. PubMed ID: 30412461
[TBL] [Abstract][Full Text] [Related]
59. Signal-enhancer molecules encapsulated liposome as a valuable sensing and amplification platform combining the aptasensor for ultrasensitive ECL immunoassay.
Mao L; Yuan R; Chai Y; Zhuo Y; Xiang Y
Biosens Bioelectron; 2011 Jun; 26(10):4204-8. PubMed ID: 21561758
[TBL] [Abstract][Full Text] [Related]
60. SARS-CoV-2 Coronavirus Nucleocapsid Antigen-Detecting Half-Strip Lateral Flow Assay Toward the Development of Point of Care Tests Using Commercially Available Reagents.
Grant BD; Anderson CE; Williford JR; Alonzo LF; Glukhova VA; Boyle DS; Weigl BH; Nichols KP
Anal Chem; 2020 Aug; 92(16):11305-11309. PubMed ID: 32605363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
